Monitoring predominantly cytostatic treatment response with 18F-FDG PET. (2009)

First Author: Contractor KB
Attributed to:  Molecular Therapy funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.2967/jnumed.108.057273

PubMed Identifier: 19403880

Publication URI: http://europepmc.org/abstract/MED/19403880

Type: Journal Article/Review

Volume: 50 Suppl 1

Parent Publication: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

ISSN: 0161-5505